These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9174874

  • 1. Nilvadipine in hypertension--experience in ambulatory treatment.
    Hoffmann A, Kraul H, Burkardt I.
    Int J Clin Pharmacol Ther; 1997 May; 35(5):195-203. PubMed ID: 9174874
    [Abstract] [Full Text] [Related]

  • 2. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial.
    Leonetti G, Italian Study Group on Nilvadipine in Mild to Moderate Hypertension.
    Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C.
    Curr Med Res Opin; 2003 Jun; 19(3):226-37. PubMed ID: 12803737
    [Abstract] [Full Text] [Related]

  • 5. Amlodipine: a double-blind evaluation of the dose-response relationship in mild to moderate hypertension.
    Frick MH, McGibney D, Tyler HM.
    J Cardiovasc Pharmacol; 1988 Jun; 12 Suppl 7():S76-8. PubMed ID: 2467135
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Calcium antagonists as first-line antihypertensive agents: a placebo-controlled, comparative trial of isradipine and nifedipine.
    Welzel D, Burger KJ, Weidinger G.
    J Cardiovasc Pharmacol; 1990 Jun; 15 Suppl 1():S70-4. PubMed ID: 1695308
    [Abstract] [Full Text] [Related]

  • 8. The long-term efficacy and safety profile of barnidipine.
    Smilde JG.
    Int J Clin Pract Suppl; 2000 Nov; (114):20-6. PubMed ID: 11221291
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
    Koseki N, Araie M, Tomidokoro A, Nagahara M, Hasegawa T, Tamaki Y, Yamamoto S.
    Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
    [Abstract] [Full Text] [Related]

  • 11. Bisoprolol and nifedipine SR in the treatment of hypertension in the elderly.
    Oliván Martinez J, Garcia MJ, Rodriguez Botaro A, Pizarro JL, Carretero J, Garrido M.
    J Cardiovasc Pharmacol; 1990 Nov; 16 Suppl 5():S95-9. PubMed ID: 11527144
    [Abstract] [Full Text] [Related]

  • 12. The tolerability of nilvadipine compared to nifedipine in patients with essential hypertension.
    Faust G.
    J Cardiovasc Pharmacol; 1992 Nov; 20 Suppl 6():S56-61. PubMed ID: 1283191
    [Abstract] [Full Text] [Related]

  • 13. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S, Rietbrock S, Thürmann P.
    Arzneimittelforschung; 1994 Feb; 44(2):133-6. PubMed ID: 8147945
    [Abstract] [Full Text] [Related]

  • 14. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group.
    Lorimer AR, Smedsrud T, Walker P, Tyler HM.
    J Hum Hypertens; 1989 Jun; 3(3):191-6. PubMed ID: 2527993
    [Abstract] [Full Text] [Related]

  • 15. Prospective controlled trial of two nifedipine extended release formulations in the treatment of essential hypertension.
    Pivac N, Naranca M, Vujic-Podlipec D, Bagatin J, Rumboldt Z.
    Arzneimittelforschung; 2002 Jun; 52(5):379-84. PubMed ID: 12087923
    [Abstract] [Full Text] [Related]

  • 16. 24-hour blood pressure control after single daily doses of nivaldipine in patients with essential hypertension.
    Lossnitzer K, Huber HJ, Kuchlbauer R, Quitzdorff G.
    J Cardiovasc Pharmacol; 1992 Jun; 20 Suppl 6():S35-42. PubMed ID: 1283187
    [Abstract] [Full Text] [Related]

  • 17. Treatment of hypertension in the very old.
    Otterstad JE, Ruilope LM.
    Int J Clin Pract Suppl; 2000 Nov; (114):10-9. PubMed ID: 11221289
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J, Poirier L, Archambault F, Jewell D, Reed CV, Lacourcière Y.
    Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
    [Abstract] [Full Text] [Related]

  • 19. Clinic blood pressure responses to two amlodipine salt formulations, adipate and besylate, in adult Korean patients with mild to moderate hypertension: a multicenter, randomized, double-blind, parallel-group, 8-week comparison.
    Lee HY, Kang HJ, Koo BK, Oh BH, Heung-Sun K, Kim KS, Seo HS, Ro YM, Kang JH, Woong CJ, Joo SJ, Kim MH, Joon-Han S, Yoon J, Park SH, Jin-Ok J, Ju AK, Chong-Yun R, Yeon KJ, Park KM, Lim DK, Park SY, Amostar Study Investigators.
    Clin Ther; 2005 Jun; 27(6):728-39. PubMed ID: 16117979
    [Abstract] [Full Text] [Related]

  • 20. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
    Hermida RC, Calvo C, Ayala DE, López JE, Rodríguez M, Chayán L, Mojón A, Fontao MJ, Fernández JR.
    Chronobiol Int; 2007 Jun; 24(3):471-93. PubMed ID: 17612946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.